Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    FLI1
Show Display Options
Rank Status Study
1 Recruiting Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX
2 Recruiting TK216 in Patients With Relapsed or Refractory Ewing Sarcoma
Condition: Sarcoma, Ewing
Intervention: Drug: TK216
3 Terminated
Has Results
Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
Conditions: Ewing Sarcoma;   Sarcoma
Intervention: Drug: Mithramycin
4 Completed Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
Condition: Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
5 Unknown  Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
Conditions: Severe Sepsis;   Septic Shock

Indicates status has not been verified in more than two years